Clinical trial
Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's…
NCT00369603 · Duke University, Other · Terminated
Key facts
| NCT number | NCT00369603 |
|---|---|
| Title | Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients |
| Official title | Functional Neuroimaging (fMRI) Biomarker of Allosteric Nicotinic Receptor Modulation in Mild Alzheimer's Disease Patients: A Razadyne vs. Aricept Dose Escalation Trial |
| Lead sponsor | Duke University, Other |
| Collaborators | Ortho-McNeil Neurologics, Inc. Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Razadyne ER, Aricept |
| Enrollment | 4 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Aug 29, 2006 |
| Last update posted | Apr 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: